Tag: Long Grove Pharmaceuticals
Optiscan taps US manufacturer Long Grove Pharmaceuticals for surgical imaging partnership
Optiscan Imaging has entered a five-year collaboration with US drug manufacturer Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein sodium contrast agent used in surgical imaging.
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
